
Mukka Proteins Ltd.
Stock Scores
14.9 / 100
96.1 / 100
44.0 / 100
49.8 / 100
Key Metrics
Stock Analysis
Fundamental analysis overview of Mukka Proteins Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Stock is cheap and PE TTM is at a discount to industry median
PE TTM of 13.08 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -34.8%
What is P/E Ratio?
Strong revenue growth and above median growth of industry
The company delivered strong revenue growth of 44.02% for 12-month ended 31 Mar 2026 and the growth was 29.81 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Low but stable operating margin
The company reported low operating margin of 6.76% for 12-month ended 31 Mar 2026 and operating margin declined marginally by -132 bps from 1 year ago
What is Operating profit margin?
Reasonable Debt to Equity, but increasing
The company has reasonable Debt to Equity of 1.56 as on 31 Mar 2026 but Debt to Equity increased by 0.53 in the last 1 year
What is Debt to Equity?
Company's earnings are of low quality
Earnings quality score of 16.1 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
16.1 / 100
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Moderate and stable ROE
The company reported moderate ROE of 11.08% for 12-month ended 31 Mar 2026 and ROE declined marginally by -1 bps from 1 year ago
What is ROE (FY)?
Moderate EPS growth and in line with median growth of industry
The company delivered moderate EPS growth of 12.36% for 12-month ended 31 Mar 2026 and the growth was 1.02 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Financial Snapshot
See detailed analysisMulti-year trends for Mukka Proteins Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Mukka Proteins Ltd. shares as reported to NSE and BSE.
| Name | Date | Type | Price | Qty. | Value |
|---|---|---|---|---|---|
| DIPAN MEHTA COMMODITIES PRIVATE LIMITED | 16 Jul 2024 | sell | ₹ 53.93 | 16.69 lac | ₹ 9.00 cr |
| GRAVITON RESEARCH CAPITAL LLP | 16 Jul 2024 | buy | ₹ 52.96 | 29.50 lac | ₹ 15.62 cr |
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITED . | 16 Jul 2024 | buy | ₹ 56.06 | 19.85 lac | ₹ 11.13 cr |
| NK SECURITIES RESEARCH PRIVATE LIMITED | 16 Jul 2024 | sell | ₹ 53.62 | 24.07 lac | ₹ 12.91 cr |
| NK SECURITIES RESEARCH PRIVATE LIMITED | 16 Jul 2024 | buy | ₹ 53.59 | 24.07 lac | ₹ 12.90 cr |
| HRTI PRIVATE LIMITED | 16 Jul 2024 | sell | ₹ 53.16 | 44.23 lac | ₹ 23.51 cr |
| HRTI PRIVATE LIMITED | 16 Jul 2024 | buy | ₹ 53.14 | 45.06 lac | ₹ 23.94 cr |
| GRAVITON RESEARCH CAPITAL LLP | 16 Jul 2024 | sell | ₹ 53.04 | 29.50 lac | ₹ 15.65 cr |
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITED . | 16 Jul 2024 | sell | ₹ 54.06 | 19.85 lac | ₹ 10.73 cr |
| DIPAN MEHTA COMMODITIES PRIVATE LIMITED | 16 Jul 2024 | buy | ₹ 54.24 | 17.68 lac | ₹ 9.59 cr |
No corporate action data available.
Company Profile
Overview of Mukka Proteins Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.